Company / Operating Income per Share
BioNexus Gene Lab Corp Operating Income per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$1.65
FY2025
5-year range
-$1.65 / $0.01
FY2021-FY2025
Trend
-1752.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share changed -1753% YoY in FY2025, a notable deviation from the 6-year average annual change of -1980%.
Based on SEC 10-K filings.
-1.65 in FY2025.
Declined from $-0.18 to $-1.65 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income per share decreased 1752.7% year-over-year.
- Peak operating income per share was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score 5.27 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.65 | -1752.7% |
| FY2024 | -$0.09 | +50.3% |
| FY2023 | -$0.18 | -10434.9% |
| FY2022 | -$0.00 | -127.6% |
| FY2021 | $0.01 | -50.3% |
| FY2020 | $0.01 | +435.6% |
| FY2019 | -$0.00 | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026